Expression of an atherogenic dyslipidemic phenotype in the postprandial period

American Journal of Cardiology

Volumn 91, Issue 2, 2003, Pages 258-

  Twickler, Marcel ^a   Cramer, Maarten Jan ^a   Erkelens, Willem ^a  

^a NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL DERIVATIVE; LIPOPROTEIN; REMNANT LIKE PARTICLE CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DRUG EFFECT; DYSLIPIDEMIA; ENDOTHELIUM CELL; FAMILIAL HYPERCHOLESTEROLEMIA; GENE EXPRESSION; GROWTH HORMONE DEFICIENCY; HUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; SYMPATHETIC TONE; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENERGIC BETA-ANTAGONISTS; ARTERIOSCLEROSIS; CHOLESTEROL; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 0037299645     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03019-9     Document Type: Letter

References (8)

1. Boccalandro F., Farias J., Boccalandro C., Vaisman D. Frequency of postprandial lipemia after a first acute coronary event (unstable angina pectoris or non-ST-segment elevation acute myocardial infarction) and the effects of atenolol on the lipemia. Am J Cardiol. 90:2002;153-156.
2. Twickler T.B., Dallinga-Thie G.M., de Valk H.W., Schreuder P.C., Jansen H., Cabezas M.C., Erkelens D.W. High dose of simvastatin normalizes postprandial remnant-like particle response in patients with heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 20:2000;2422-2427.
3. Twickler T.B., Wilmink H.W., Schreuder P.C., Cabezas M.C., van Dam P.S., Koppeschaar H.P., Erkelens D.W., Dallinga-Thie G.M. Growth hormone (GH) treatment decreases postprandial remnant-like particle cholesterol concentration and improves endothelial function in adult-onset GH deficiency. J Clin Endocrinol Metab. 85:2000;4683-4689.
4. Karpe F., Boquist S., Tang R., Bond G.M., de Faire U., Hamsten A. Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. J Lipid Res. 42:2001;17-21.
5. Wilmink H.W., Twickler ThB, Banga J.D., Dallinga-Thie G.M., Eeltink H., Erkelens D.W., Rabelink T.J., Stroes E.S. Effect of statin versus fibrate on postprandial endothelial dysfunction role of remnant-like particles. Cardiovasc Res. 50:2001;577-582.
6. Schreuder P.C., Twickler T.B., Wang T., Nakajima K., Erkelens D.W., Dallinga-Thie G.M. Isolation of remnant particles by immunoseparation a new approach for investigation of postprandial lipoprotein metabolism in normolipidemic subjects. Atherosclerosis. 157:2001;145-150.
7. Kugiyama K., Doi H., Takazoe K., Kawano H., Soejima H., Mizuno Y., Tsunoda R., Sakamoto T., Nakano T., Nakajima K., et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation. 99:1999;2858-2860.
8. de Sauvage Nolting P.R., Twickler M.B., Dallinga-Thie G.M., Buirma R.J., Hutten B.A., Kastelein J.J. Elevated remnant-like particles in heterozygous familial hypercholesterolemia and response to statin therapy. Circulation. 106:2002;788-792.